Promoting the value of an integrated system for research and care for patients with rare progressive neuromuscular diseases like Frederich's Ataxia, ALS and Spinal MuscularAtrophy (SMA).
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|
Promoting the value of Biogen Canada's innovative product portfolio, pipeline, and research and products related to biosimilars, post partum depression, ophthalmology, Multiple Sclerosis and
other neuromuscular diseases to address patient needs.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|